A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance with Oxpentifylline (HERO) trial
Type of Publication
Journal Article
Year of Publication
2014
Journal
American Journal of Kidney Diseases
Language
Eng
ISBN Number
1523-6838 (Electronic)<br/>0272-6386 (Linking)
Volume
pii: S0272-6386(14)00987-1.
Links to full text